INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

21,591 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
10
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$84K
3,097 sh
Feb 3, 2026Feb 3, 2026
Page 408 of 540
← PrevNext →
traded Feb 3, 2026
+0d
SEC Form 4

Evidence

10
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

9
OC
Ohlgart ChristianeChief Financial Officer
FTNTFortinet, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
507 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

6
JD
Jedrzejek DavidSVP and General Counsel
LEVILEVI STRAUSS & CO
Open-market sale · 10b5-1 plan
SELL$44K
2,248 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

4
BP
Badjate PramodPresident & GM, NFB
NTGRNETGEAR, INC.
Open-market sale · 10b5-1 plan
SELL$63K
3,000 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

1
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$38K
1,462 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

39
DJ
Donovan James JosephChief Lending Officer/FSVP
UNTYUNITY BANCORP INC /NJ/
Open-market sale
SELL$14K
265 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

35
KE
Krohne Susan EChief Legal Officer, Secretary
MHOM/I HOMES, INC.
Open-market sale
SELL$671K
5,000 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

22
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$154K
3,500 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

22
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
2,800 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

21
Thomas RagyDirector
CXMSprinklr, Inc.
Open-market sale
SELL$6,693
1,054 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$184
2 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$30K
315 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

18
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$40K
4,533 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

18
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
1,200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

14
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
3,375 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$4,365
25.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

56
BJ
Baker JeffPrincipal Accounting Officer
CRWVCoreWeave, Inc.
Open-market sale
SELL$534K
5,143 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

48
SV
Sharma VipulChief Technology Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$3.57M
200.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

48
LN
Lantz Erin NChief Revenue Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$2.91M
162.7K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

45
TK
Terence E. Adderley Revocable Trust K10% Owner
KELYBKELLY SERVICES INC
Open-market sale
SELL$106.00M
3.04M sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.31M
21.9K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.12M
10.7K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

39
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$179K
13.7K sh
Nov 11, 2025Jan 30, 2026
traded Nov 11, 2025
+80dSEC Form 4

Evidence

38
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$255K
21.5K sh
Nov 14, 2025Jan 30, 2026
traded Nov 14, 2025
+77dSEC Form 4

Evidence

38
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
728 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

38
KW
Kucharski Brandt WalterChief Accounting Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$222K
12.4K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$80K
4,797 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$59K
3,588 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
2,304 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$322K
2,974 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$586K
5,511 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$68K
6,000 sh
Nov 18, 2025Jan 30, 2026
traded Nov 18, 2025
+73dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$89K
8,000 sh
Nov 19, 2025Jan 30, 2026
traded Nov 19, 2025
+72dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$230K
19.0K sh
Nov 17, 2025Jan 30, 2026
traded Nov 17, 2025
+74dSEC Form 4

Evidence

34
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$72K
4,333 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
1,031 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
949 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.40M
96.9K sh
Jan 15, 2026Jan 30, 2026
traded Jan 15, 2026
+15dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.22M
83.0K sh
Jan 12, 2026Jan 30, 2026
traded Jan 12, 2026
+18dSEC Form 4

Evidence